Anna Protopapas Nuvalent, Inc. (NUVL) insider trading activity

NUVL Quotes by TradingView

Anna Protopapas is of Nuvalent, Inc.. Currently has a direct ownership of 2,499 shares of NUVL, which is worth approximately $237,230. The most recent transaction as insider was on Jun 12, 2024, when has been sold 2,499 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.5K
0% 3M change
n/a 12M change
Total Value Held $237,230

Anna Protopapas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,499 Added 50.0%
2,499 Class A Common Stock
Dec 18 2023
SELL
Open market or private sale
$378,350 $75.67 p/Share
5,000 Reduced 100.0%
0 Class A Common Stock
Dec 18 2023
BUY
Exercise of conversion of derivative security
$46,800 $9.36 p/Share
5,000 Added 50.0%
5,000 Class A Common Stock

Also insider at

MRSN
Mersana Therapeutics, Inc. Healthcare
Director
DRNA
Dicerna Pharmaceuticals Inc
Director
AP

Anna Protopapas

Cambridge, MA

Track Institutional and Insider Activities on NUVL

Follow Nuvalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVL shares.

Notify only if

Insider Trading

Get notified when an Nuvalent, Inc. insider buys or sells NUVL shares.

Notify only if

News

Receive news related to Nuvalent, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NUVL